Clinical Domain Working Groups

Myeloid Malignancy Variant Curation Expert Panel

Membership Documents

The Myeloid Malignancy Variant Curation Expert Panel (MM-VCEP) curates variants in genes associated with inherited risk for myeloid malignancies. Our panel considers variants in genes that cause life-long thrombocytopenia (e.g., RUNX1, ANKRD26, and ETV6) as well as those associated only with cancer risk (e.g., GATA2, DDX41 and CEBPA).  The MM-VCEP has collaborated with ASH, and is currently supported by the National Cancer Institute. We aim to encourage standardized variant curation, which will improve variant reporting and facilitate optimal treatment of patients and their families.

Expert Panel Status

Step 1
Step 2
Step 3
Step 4
Define Group
Completed Jun. 2018
Develop Classification Rules
Completed Jan. 2019
Pilot Rules
Completed Jul. 2019
Expert Panel Approval
Completed Jul. 2019

Documents

Expert Panel Membership

Membership spans many fields, including genetics, medical, academia, and industry.